AMILORIDE (MIDAMOR, MERCK, SHARP AND DOHME)

被引:14
作者
MACFIE, HL [1 ]
COLVIN, CL [1 ]
ANDERSON, PO [1 ]
机构
[1] NEW ENGLAND MED CTR,DEPT PHARM,BOSTON,MA 02111
来源
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1981年 / 15卷 / 02期
关键词
D O I
10.1177/106002808101500202
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:94 / 98
页数:5
相关论文
共 38 条
[1]  
BABA WI, 1968, CLIN PHARMACOL THER, V9, P318
[2]  
BAER JE, 1967, J PHARMACOL EXP THER, V157, P472
[3]  
Burge P S, 1976, Curr Med Res Opin, V4, P260, DOI 10.1185/03007997609109315
[4]  
COUNIHAN TB, 1979, BRIT J PHARMACOL, V67, pP494
[5]  
DAVIDSON C, 1973, BRIT HEART J, V35, P456
[6]  
FOSTER DW, 1980, HARRISONS PRINCIPLES, P1754
[7]  
GEORGE CF, 1973, LANCET, V2, P1288
[8]   AMILORIDE HANDLING IN RENAL-FAILURE [J].
GEORGE, CF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (01) :94-95
[9]   EFFECTS OF MK-870 IN NORMAL SUBJECTS AND HYPERTENSIVE PATIENTS [J].
GOMBOS, EA ;
FREIS, ED ;
MOGHADAM, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 275 (22) :1215-&
[10]  
GRAYSON MF, 1971, BRIT J PHARMACOL, V43, pP473